Cohance Lifesciences Limited (NSE:COHANCE)
279.90
-11.95 (-4.09%)
At close: Mar 6, 2026
-76.18% (1Y)
| Market Cap | 107.08B |
| Revenue (ttm) | 10.79B |
| Net Income (ttm) | 606.40M |
| Shares Out | 382.57M |
| EPS (ttm) | 2.35 |
| PE Ratio | 119.13 |
| Forward PE | 37.12 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,396,684 |
| Average Volume | 1,749,581 |
| Open | 290.35 |
| Previous Close | 291.85 |
| Day's Range | 276.00 - 295.00 |
| 52-Week Range | 276.70 - 1,250.00 |
| Beta | 0.15 |
| RSI | 22.15 |
| Earnings Date | Feb 12, 2026 |